Age-Related Macular Degeneration and Blindness due to Neovascular Maculopathy, Archives of Ophthalmology, vol.102, issue.11, pp.1640-1642, 1960. ,
DOI : 10.1001/archopht.1984.01040031330019
The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration, Ophthalmology, vol.115, issue.1, pp.116-142, 2008. ,
DOI : 10.1016/j.ophtha.2007.03.008
Prevalence of Age-Related Maculopathy in Older Europeans, Archives of Ophthalmology, vol.124, issue.4, pp.529-564, 1960. ,
DOI : 10.1001/archopht.124.4.529
Prevalence of age-related maculopathy. The Beaver Dam Eye Study, Ophthalmology, vol.99299, issue.6, pp.933-976 ,
DOI : 10.1016/s0161-6420(92)31871-8
The Five-year Incidence and Progression of Age-related Maculopathy, Ophthalmology, vol.104, issue.1, pp.7-21, 1997. ,
DOI : 10.1016/S0161-6420(97)30368-6
Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study1 1The authors have no proprietary interest in the products or devices mentioned herein., Ophthalmology, vol.109, issue.10, pp.1767-79, 2002. ,
DOI : 10.1016/S0161-6420(02)01146-6
Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population The Copenhagen City Eye Study, Ophthalmology, vol.108, issue.12, pp.2347-57, 2001. ,
DOI : 10.1016/S0161-6420(01)00823-5
Causes of Blindness and Visual Impairment in Urban and Rural Areas in Beijing, Ophthalmology, vol.113, issue.7, pp.1134-1135, 2006. ,
DOI : 10.1016/j.ophtha.2006.01.035
Prevalence and Causes of Low Vision and Blindness in a Japanese Adult Population, Ophthalmology, vol.113, issue.8 ,
DOI : 10.1016/j.ophtha.2006.04.022
Rapid Assessment of Avoidable Blindness in Nakuru District, Kenya, Ophthalmology, vol.114, issue.3, pp.599-605, 2007. ,
DOI : 10.1016/j.ophtha.2006.06.057
Drusen and Disciform Macular Detachment and Degeneration, Archives of Ophthalmology, vol.90, issue.3, pp.409-445, 1972. ,
DOI : 10.1001/archopht.1973.01000050208006
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310465/pdf
The US Twin Study of Age-Related Macular Degeneration, Archives of Ophthalmology, vol.123, issue.3, pp.321-328, 1960. ,
DOI : 10.1001/archopht.123.3.321
Complement Factor H Polymorphism in Age-Related Macular Degeneration, Science, vol.308, issue.5720, pp.385-394, 2005. ,
DOI : 10.1126/science.1109557
Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population, Mol Vis, vol.11, pp.1135-1175, 2005. ,
A prospective study ,
Hypothetical
LOC387715
is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk, Human Molecular Genetics, vol.14, issue.21, pp.3227-3263, 2005. ,
DOI : 10.1093/hmg/ddi353
CFH and LOC387715/ARMS2 Genotypes and Treatment with Antioxidants and Zinc for Age-Related Macular Degeneration, Ophthalmology, vol.115, issue.6, pp.1019-1044, 2008. ,
DOI : 10.1016/j.ophtha.2008.01.036
Association of Complement Factor H and LOC387715 Genotypes with Response of Exudative Age-Related Macular Degeneration to Intravitreal Bevacizumab, Ophthalmology, vol.114, issue.12, pp.2168-73, 2007. ,
DOI : 10.1016/j.ophtha.2007.09.008
Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab, British Journal of Ophthalmology, vol.93, issue.5, pp.610-613, 2009. ,
DOI : 10.1136/bjo.2008.150995
Genetic Influences on the Outcome of Anti-Vascular Endothelial Growth Factor Treatment in Neovascular Age-related Macular Degeneration, Ophthalmology, vol.120, issue.8, pp.1641-1649, 2013. ,
DOI : 10.1016/j.ophtha.2013.01.014
PHARMACOGENOMICS OF RESPONSE TO ANTI-VEGF THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION, Retina, vol.35, issue.3, pp.381-91, 2015. ,
DOI : 10.1097/IAE.0000000000000466
Association between variants A69S in ARMS2 gene and response to treatment of exudative AMD: a meta-analysis, British Journal of Ophthalmology, vol.127, issue.5, pp.593-601, 2015. ,
DOI : 10.1007/s00439-010-0805-8
Association of CFH Y402H and LOC387715 A69S With Progression of Age-Related Macular Degeneration, JAMA, vol.297, issue.16, pp.1793-800, 2007. ,
DOI : 10.1001/jama.297.16.1793
The Three-Year Incidence of Age-Related Macular Degeneration: The ???Pathologies Oculaires Li??es ?? l???Age??? (POLA) Prospective Study, American Journal of Ophthalmology, vol.140, issue.5, pp.924-930, 2005. ,
DOI : 10.1016/j.ajo.2005.05.002
A simplified severity scale for age-related macular degeneration: AREDS Report No. 18, Arch Ophthalmol Chic Ill, vol.123, issue.11, pp.1570-1574, 1960. ,
The epidemiology of age-related macular degeneration, American Journal of Ophthalmology, vol.137, issue.3, pp.486-95, 2004. ,
DOI : 10.1016/j.ajo.2003.11.069
Prevalence of Age-Related Macular Degeneration in 4 Racial/Ethnic Groups in the Multi-ethnic Study of Atherosclerosis, Ophthalmology, vol.113, issue.3, pp.373-80, 2006. ,
DOI : 10.1016/j.ophtha.2005.12.013
Smoking and agerelated macular degeneration: a review of association, Eye Lond Engl, vol.19, issue.9, pp.935-979, 2005. ,
The <i>LOC387715 </i>Gene, Smoking, Body Mass Index, Environmental Associations with Advanced Age-Related Macular Degeneration, Human Heredity, vol.63, issue.3-4, pp.212-220, 2007. ,
DOI : 10.1159/000100046
The relationship of dietary lipid intake and age-related macular degeneration in a case-control study, AREDS Report No. Arch Ophthalmol Chic Ill, vol.20125, issue.5, pp.671-680, 1960. ,
The Bowman lecture. Towards an understanding of age-related macular disease, Eye Lond Engl, vol.17, issue.4, pp.457-66, 2003. ,
Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies, Survey of Ophthalmology, vol.48, issue.3, pp.257-93, 2003. ,
DOI : 10.1016/S0039-6257(03)00030-4
Association Between C-Reactive Protein and Age-Related Macular Degeneration, JAMA, vol.291, issue.6, pp.704-714, 2004. ,
DOI : 10.1001/jama.291.6.704
URL : http://jama.jamanetwork.com/data/journals/jama/4915/joc31989.pdf
Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration, American Journal of Ophthalmology, vol.130, issue.6, pp.769-73, 2000. ,
DOI : 10.1016/S0002-9394(00)00552-3
Immunological and Aetiological Aspects of Macular Degeneration, Progress in Retinal and Eye Research, vol.20, issue.3, pp.385-414, 2001. ,
DOI : 10.1016/S1350-9462(00)00025-2
A role for local inflammation in the formation of drusen in the aging eye, American Journal of Ophthalmology, vol.134, issue.3, pp.411-442, 2002. ,
DOI : 10.1016/S0002-9394(02)01624-0
An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration, Progress in Retinal and Eye Research, vol.20, issue.6, pp.705-737, 2001. ,
DOI : 10.1016/S1350-9462(01)00010-6
Vascular-specific growth factors and blood vessel formation, Nature, vol.407, issue.6801, pp.242-250, 2000. ,
DOI : 10.1038/35025215
Correlation of Increased Vascular Endothelial Growth Factor With Neovascularization and Permeability in Ischemic Central Vein Occlusion, Archives of Ophthalmology, vol.120, issue.12, pp.1644-50, 1960. ,
DOI : 10.1001/archopht.120.12.1644
Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy, American Journal of Ophthalmology, vol.134, issue.3, pp.348-53, 2002. ,
DOI : 10.1016/S0002-9394(02)01568-4
Expression of vascular endothelial growth factor in experimental choroidal neovascularization, Graefe's Archive for Clinical and Experimental Ophthalmology, vol.80, issue.3, pp.159-67, 1997. ,
DOI : 10.1007/BF00941723
Increased expression of angiogenic growth factors in age-related maculopathy, British Journal of Ophthalmology, vol.81, issue.2, pp.154-62, 1997. ,
DOI : 10.1136/bjo.81.2.154
Subfoveal fibrovascular membranes in agerelated macular degeneration express vascular endothelial growth factor, Invest Ophthalmol Vis Sci, vol.37, issue.9, pp.1929-1963, 1996. ,
DOI : 10.1016/s0002-9394(14)70522-7
Retinal and choroidal neovascularization, Journal of Cellular Physiology, vol.235, issue.3, pp.301-311, 2000. ,
DOI : 10.1002/(SICI)1097-4652(199905)179:2<149::AID-JCP5>3.0.CO;2-2
OCT imaging of choroidal neovascularisation and its role in the determination of patients' eligibility for surgery, British Journal of Ophthalmology, vol.83, issue.4, pp.438-480, 1999. ,
DOI : 10.1136/bjo.83.4.438
Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina Phila Pa, pp.1333-1382, 2010. ,
Indocyanine green angiography in chorioretinal diseases: indications and interpretation, Ophthalmology, vol.110, issue.1, pp.15-21, 2003. ,
DOI : 10.1016/S0161-6420(02)01563-4
Diagnostic Evaluation of Type 2 (Classic) Choroidal Neovascularization: Optical Coherence Tomography, Indocyanine Green Angiography, and Fluorescein Angiography, American Journal of Ophthalmology, vol.152, issue.5, pp.799-806, 2011. ,
DOI : 10.1016/j.ajo.2011.04.011
TYPE 3 NEOVASCULARIZATION, Retina, vol.28, issue.2, pp.201-212, 2008. ,
DOI : 10.1097/IAE.0b013e3181669504
Review of Retinal Angiomatous Proliferation or Type 3 Neovascularization, Retina, vol.28, issue.3, pp.375-84, 2008. ,
DOI : 10.1097/IAE.0b013e3181619c55
RETINAL ANGIOMATOUS PROLIFERATION IN AGE-RELATED MACULAR DEGENERATION, Retina, vol.21, issue.5, pp.416-450, 2001. ,
DOI : 10.1097/00006982-200110000-00003
Focal Inner Retinal Hemorrhages in Patients with Drusen, RETINA, vol.23, issue.6, pp.741-51, 2003. ,
DOI : 10.1097/00006982-200312000-00001
The natural history of occult choroidal neovascularisation associated with age-related macular degeneration. A systematic review, Ann Acad Med Singapore, vol.35, issue.3, pp.145-50, 2006. ,
Occult Subretinal New Vessels in Age-related Macular Degeneration, Ophthalmology, vol.97, issue.5, pp.649-57, 1990. ,
DOI : 10.1016/S0161-6420(90)32530-7
A combined technique of fluorescein funduscopy and agiography of the eye Macular degeneration related to age and cystoid macular edema. Apropos of 95 cases (100 eyes), Arch Ophthalmol Chic Ill J Fr Ophtalmol, vol.7811, issue.411, pp.711-731, 1960. ,
NATURE AND RISK OF NEOVASCULARIZATION IN THE FELLOW EYE OF PATIENTS WITH UNILATERAL RETINAL ANGIOMATOUS PROLIFERATION, Retina, vol.25, issue.6, pp.713-721, 2005. ,
DOI : 10.1097/00006982-200509000-00005
Imaging of Chorioretinal Anastomoses in Vascularized Retinal Pigment Epithelium Detachments, Archives of Ophthalmology, vol.113, issue.11, pp.1392-1400, 1960. ,
DOI : 10.1001/archopht.1995.01100110052025
ANGIOGRAPHIC ANALYSIS OF RETINAL???CHOROIDAL ANASTOMOSIS BY CONFOCAL SCANNING LASER OPHTHALMOSCOPY TECHNOLOGY AND CORRESPONDING (EYE-TRACKED) SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY, Retina, vol.30, issue.2, pp.222-256, 2010. ,
DOI : 10.1097/IAE.0b013e3181bceef0
Development of Subretinal Fibrosis After Anti-VEGF Treatment in Neovascular Age-Related Macular Degeneration, Ophthalmic Surgery, Lasers, and Imaging, vol.42, issue.1, pp.6-11, 2011. ,
DOI : 10.3928/15428877-20100924-01
Subfoveal Fibrosis in Eyes With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab, American Journal of Ophthalmology, vol.156, issue.1, pp.116-124, 2013. ,
DOI : 10.1016/j.ajo.2013.02.012
Regression of Choroidal Neovascularization Results in Macular Atrophy in Anti-Vascular Endothelial Growth Factor-Treated Eyes, American Journal of Ophthalmology, vol.159, issue.1, pp.9-19, 2015. ,
DOI : 10.1016/j.ajo.2014.09.012
ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION, Retina, vol.35, issue.10, pp.1957-63, 2015. ,
DOI : 10.1097/IAE.0000000000000583
CAUSES OF UNSUCCESSFUL RANIBIZUMAB TREATMENT IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION IN CLINICAL SETTINGS, Retina, vol.32, issue.8, pp.1480-1485, 2012. ,
DOI : 10.1097/IAE.0b013e318240a516
Characteristics of Patients Losing Vision after 2 Years of Monthly Dosing in the Phase III Ranibizumab Clinical Trials, Ophthalmology, vol.118, issue.3, pp.523-553, 2011. ,
DOI : 10.1016/j.ophtha.2010.07.011
Outer Retinal Tubulation, Archives of Ophthalmology, vol.127, issue.12, pp.1596-602, 1960. ,
DOI : 10.1001/archophthalmol.2009.326
Comparison of fluorescein angiography and indocyanine green angiography for imaging of choroidal neovascularization in hemorrhagic age-related macular degeneration, American Journal of Ophthalmology, vol.129, issue.4, pp.495-500, 2000. ,
DOI : 10.1016/S0002-9394(99)00388-8
Age-related Macular Degeneration and Antioxidant Status in the POLA Study, Archives of Ophthalmology, vol.117, issue.10, pp.1384-90, 1960. ,
DOI : 10.1001/archopht.117.10.1384
Dietary Antioxidants and the Long-term Incidence of Age-Related Macular Degeneration, Ophthalmology, vol.115, issue.2 ,
DOI : 10.1016/j.ophtha.2007.03.083
Dietary Fatty Acids and the 10-Year Incidence of Age-Related Macular Degeneration, Archives of Ophthalmology, vol.127, issue.5, pp.656-65, 1960. ,
DOI : 10.1001/archophthalmol.2009.76
Folic Acid, Pyridoxine, and Cyanocobalamin Combination Treatment and Age-Related Macular Degeneration in Women, Archives of Internal Medicine, vol.169, issue.4, pp.335-376, 2009. ,
DOI : 10.1001/archinternmed.2008.574
Macular pigment in donor eyes with and without AMD: a case-control study, Invest Ophthalmol Vis Sci, vol.42, issue.1, pp.235-275, 2001. ,
The Role of Oxidative Stress in the Pathogenesis of Age-Related Macular Degeneration, Survey of Ophthalmology, vol.45, issue.2, pp.115-149, 2000. ,
DOI : 10.1016/S0039-6257(00)00140-5
Preservation of visual sensitivity of older subjects: association with macular pigment density, Invest Ophthalmol Vis Sci, vol.39, issue.2, pp.397-406, 1998. ,
The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22, Arch Ophthalmol Chic Ill, vol.125, issue.9, pp.1225-1257, 1960. ,
Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial), Optometry - Journal of the American Optometric Association, vol.75, issue.4, pp.216-246, 2004. ,
DOI : 10.1016/S1529-1839(04)70049-4
The Relationship of Dietary ??-3 Long-Chain Polyunsaturated Fatty Acid Intake With Incident Age-Related Macular Degeneration, Archives of Ophthalmology, vol.126, issue.9, pp.1274-1283, 1960. ,
DOI : 10.1001/archopht.126.9.1274
??-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study, American Journal of Clinical Nutrition, vol.90, issue.6, pp.1601-1608, 2009. ,
DOI : 10.3945/ajcn.2009.27594
Oral Docosahexaenoic Acid in the Prevention of Exudative Age-Related Macular Degeneration, Ophthalmology, vol.120, issue.8, pp.1619-1650, 2013. ,
DOI : 10.1016/j.ophtha.2013.01.005
Argon laser photocoagulation of subretinal neovascularization in senile macular degeneration. Results of a randomized study of 60 cases], Bull Mem Soc Fr Ophtalmol, vol.94, pp.149-54, 1982. ,
Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2, Arch Ophthalmol Chic Ill, vol.119, issue.2, pp.198-207, 1960. ,
Verteporfin PDT for subfoveal occult CNV in AMD: two-year results of a randomized trial, Current Medical Research and Opinion, vol.25, issue.8, pp.1853-60, 2009. ,
DOI : 10.1185/03007990903038616
Clinical Trial Group Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials, Ophthalmology, vol.113, issue.6, pp.992-1001, 2006. ,
Ranibizumab for Neovascular Age-Related Macular Degeneration, New England Journal of Medicine, vol.355, issue.14, pp.1419-1450, 2006. ,
DOI : 10.1056/NEJMoa054481
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration, New England Journal of Medicine, vol.355, issue.14, pp.1432-1476, 2006. ,
DOI : 10.1056/NEJMoa062655
Ranibizumab and bevacizumab for neovascular age-related macular degeneration, N Engl J Med, vol.364, issue.20, pp.1897-908, 2011. ,
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results, Ophthalmology, vol.119, issue.7, pp.1388-98, 2012. ,
Intravitreal Bevacizumab Versus Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration, Ophthalmology, vol.123, issue.1, pp.70-77, 2016. ,
DOI : 10.1016/j.ophtha.2015.09.002
Retrospective Analysis of First-Line Anti-Vascular Endothelial Growth Factor Treatment Patterns in Wet Age-Related Macular Degeneration, Advances in Therapy, vol.45, issue.6, pp.1111-1138, 2013. ,
DOI : 10.1016/0895-4356(92)90133-8
First-Year Visual Acuity Outcomes of Providing Aflibercept According to the VIEW Study Protocol for Age-Related Macular Degeneration, Ophthalmology, vol.123, issue.2, pp.337-380, 2016. ,
DOI : 10.1016/j.ophtha.2015.09.039
Bimonthly Ranibizumab for Neovascular Age-Related Macular Degeneration, Ophthalmologica, vol.231, issue.2, pp.80-85, 2014. ,
DOI : 10.1159/000356401
Bevacizumab in age-related macular degeneration: a randomized controlled trial on the effect of injections every 4???weeks, 6???weeks and 8???weeks, Acta Ophthalmologica, vol.118, issue.6, pp.456-461, 2013. ,
DOI : 10.1016/j.ophtha.2010.09.004
A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study, American Journal of Ophthalmology, vol.148, issue.1, pp.43-58, 2009. ,
DOI : 10.1016/j.ajo.2009.01.024
Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study, Ophthalmology, vol.118, issue.4, pp.663-71, 2011. ,
DOI : 10.1016/j.ophtha.2010.12.019
Evaluation of Injection Frequency and Visual Acuity Outcomes for Ranibizumab Monotherapy in Exudative Age-related Macular Degeneration, Ophthalmology, vol.116, issue.9, pp.1740-1747, 2009. ,
DOI : 10.1016/j.ophtha.2009.05.033
Results of One-Year's Treatment with Ranibizumab for Exudative Age-related Macular Degeneration in a Clinical Setting, American Journal of Ophthalmology, vol.148, issue.3, pp.409-422, 2009. ,
DOI : 10.1016/j.ajo.2009.04.001
Ranibizumab According to Need: A Treatment for Age-related Macular Degeneration, American Journal of Ophthalmology, vol.143, issue.4, pp.679-80, 2007. ,
DOI : 10.1016/j.ajo.2007.02.024
The As-Needed Treatment Strategy for Choroidal Neovascularization: A Feedback-Based Treatment System, American Journal of Ophthalmology, vol.148, issue.1, pp.1-3, 2009. ,
DOI : 10.1016/j.ajo.2009.04.010
Bevacizumab for Neovascular Age-Related Macular Degeneration Using a Treat-and-Extend Regimen: Clinical and Economic Impact, American Journal of Ophthalmology, vol.153, issue.3, pp.468-473, 2012. ,
DOI : 10.1016/j.ajo.2011.08.011
INJECT AND EXTEND DOSING VERSUS DOSING AS NEEDED, Retina, vol.31, issue.1, pp.26-30, 2011. ,
DOI : 10.1097/IAE.0b013e3181de5609
Treat and Extend versus Pro Re Nata regimens of ranibizumab in neovascular age-related macular degeneration: a comparative 12 Month study, Acta Ophthalmol (Copenh), 2016. ,
Prospective study evaluating the predictability of need for retreatment with intravitreal ranibizumab for age-related macular degeneration, Graefe's Archive for Clinical and Experimental Ophthalmology, vol.364, issue.3, pp.697-704, 2013. ,
DOI : 10.1056/NEJMicm1005605
Reducing the clinical burden of ranibizumab treatment for neovascular age-related macular degeneration using an individually planned regimen, British Journal of Ophthalmology, vol.118, issue.9, pp.1192-1198, 2014. ,
DOI : 10.1016/j.ophtha.2010.12.019
Clinical pharmacokinetics of bevacizumab in patients with solid tumors, Cancer Chemotherapy and Pharmacology, vol.28, issue.5, pp.779-86, 2008. ,
DOI : 10.1007/978-1-4899-2329-5_8
Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration, Investigative Opthalmology & Visual Science, vol.46, issue.2, pp.726-759, 2005. ,
DOI : 10.1167/iovs.04-0601
Cardiovascular Events and Bleeding Risk Associated With Intravitreal Antivascular Endothelial Growth Factor Monoclonal Antibodies, JAMA Ophthalmology, vol.132, issue.11, pp.1317-1343, 2014. ,
DOI : 10.1001/jamaophthalmol.2014.2333
URL : http://archopht.jamanetwork.com/data/journals/ophth/931033/eoi140065.pdf
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration, Cochrane Database Syst Rev, vol.2, issue.2, p.11230, 2014. ,
DOI : 10.1016/S2214-109X(13)70145-1
Systemic Safety of Prolonged Monthly Anti???Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema, JAMA Ophthalmology, vol.134, issue.1, pp.21-30, 2016. ,
DOI : 10.1001/jamaophthalmol.2015.4070
Systemic Vascular Safety of Ranibizumab for Age-Related Macular Degeneration, Ophthalmology, vol.121, issue.11, pp.2193-2203, 2014. ,
DOI : 10.1016/j.ophtha.2014.05.022
The Physiological Principle of Minimum Work: I. The Vascular System and the Cost of Blood Volume, Proceedings of the National Academy of Sciences, vol.12, issue.3, pp.207-221, 1926. ,
DOI : 10.1073/pnas.12.3.207
The Physiological Principle of Minimum Work: II. Oxygen Exchange in Capillaries, Proceedings of the National Academy of Sciences, vol.12, issue.5, pp.299-304, 1926. ,
DOI : 10.1073/pnas.12.5.299
THE PHYSIOLOGICAL PRINCIPLE OF MINIMUM WORK APPLIED TO THE ANGLE OF BRANCHING OF ARTERIES, The Journal of General Physiology, vol.9, issue.6, pp.835-876, 1926. ,
DOI : 10.1085/jgp.9.6.835
The cost of departure from optimal radii in microvascular networks, Journal of Theoretical Biology, vol.136, issue.3, pp.245-65, 1989. ,
DOI : 10.1016/S0022-5193(89)80162-6
Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions, Cancer Res. 1 janv, vol.51, issue.1, pp.265-73, 1991. ,
Tumor angiogenesis: therapeutic implications, N Engl J Med, vol.285, issue.21, pp.1182-1188, 1971. ,
Prostaglandin E2 and vascular endothelial growth factor A mediate angiogenesis of human ovarian follicular endothelial cells, Human Reproduction, vol.31, issue.2, pp.436-480, 2016. ,
DOI : 10.1093/humrep/dev320
Angiogenesis in life, disease and medicine, Nature, vol.Teill II, issue.7070, pp.932-938, 2005. ,
DOI : 10.1053/j.seminoncol.2004.03.034
Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization., Proceedings of the National Academy of Sciences, vol.92, issue.17, pp.7657-61, 1995. ,
DOI : 10.1073/pnas.92.17.7657
URL : http://www.pnas.org/content/92/17/7657.full.pdf
Endothelial Cells Modulate the Proliferation of Mural Cell Precursors via Platelet-Derived Growth Factor-BB and Heterotypic Cell Contact, Circulation Research, vol.84, issue.3, pp.298-305, 1999. ,
DOI : 10.1161/01.RES.84.3.298
Lack of Pericytes Leads to Endothelial Hyperplasia and Abnormal Vascular Morphogenesis, The Journal of Cell Biology, vol.126, issue.3, pp.543-53, 2001. ,
DOI : 10.1046/j.1460-9568.1999.00502.x
Pathways mediating VEGF-independent tumor angiogenesis, Cytokine & Growth Factor Reviews, vol.21, issue.1, pp.21-27, 2010. ,
DOI : 10.1016/j.cytogfr.2009.11.003
Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody, Proceedings of the National Academy of Sciences, vol.55, issue.18, pp.14765-70, 1996. ,
DOI : 10.1146/annurev.ph.57.030195.004143
URL : http://www.pnas.org/content/93/25/14765.full.pdf
Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors, Cancer Research, vol.64, issue.11, pp.3731-3737, 2004. ,
DOI : 10.1158/0008-5472.CAN-04-0074
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy, Science, vol.307, issue.5706, pp.58-62, 2005. ,
DOI : 10.1126/science.1104819
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases, Nature Reviews Drug Discovery, vol.7, issue.6, pp.417-444, 2011. ,
DOI : 10.1038/nmeth.1475
Optical imaging of the chorioretinal vasculature in the living human eye, Proceedings of the National Academy of Sciences, vol.53, issue.1, pp.14354-14363, 2013. ,
DOI : 10.1167/iovs.11-8249
Choriocapillaris and Choroidal Microvasculature Imaging with Ultrahigh Speed OCT Angiography, PLoS ONE, vol.12, issue.12, p.81499, 2013. ,
DOI : 10.1371/journal.pone.0081499.s002
URL : https://doi.org/10.1371/journal.pone.0081499
Phase-Variance Optical Coherence Tomography, Ophthalmology, vol.121, issue.1, pp.180-187, 2014. ,
DOI : 10.1016/j.ophtha.2013.09.002
Retinal Vascular Layers Imaged by Fluorescein Angiography and Optical Coherence Tomography Angiography, JAMA Ophthalmology, vol.133, issue.1, pp.45-50, 2015. ,
DOI : 10.1001/jamaophthalmol.2014.3616
URL : http://archopht.jamanetwork.com/data/journals/ophth/931885/eoi140088.pdf
IN VIVO CHARACTERIZATION OF RETINAL VASCULARIZATION MORPHOLOGY USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY, Retina, vol.35, issue.11, pp.2196-203, 2015. ,
DOI : 10.1097/IAE.0000000000000635
Fluorescein-Induced Allergic Reaction, Annals of Allergy, Asthma & Immunology, vol.81, issue.5, pp.428-458, 1998. ,
DOI : 10.1016/S1081-1206(10)63140-7
IMAGE ARTIFACTS IN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY, Retina, vol.35, issue.11, pp.2163-80, 2015. ,
DOI : 10.1097/IAE.0000000000000765
Optical Coherence Tomography Angiography of??Type 1 Neovascularization in Age-Related Macular Degeneration, American Journal of Ophthalmology, vol.160, issue.4, pp.739-748, 2015. ,
DOI : 10.1016/j.ajo.2015.06.030
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN EARLY TYPE 3 NEOVASCULARIZATION, Retina, vol.35, issue.11, pp.2236-2277, 2015. ,
DOI : 10.1097/IAE.0000000000000834
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF SUBRETINAL FIBROSIS IN AGE-RELATED MACULAR DEGENERATION, Retina, vol.35, issue.11, pp.2275-84, 2015. ,
DOI : 10.1097/IAE.0000000000000819
DETECTION OF NONEXUDATIVE CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION WITH OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY, Retina, vol.35, issue.11, pp.2204-2215, 2015. ,
DOI : 10.1097/IAE.0000000000000867
Optical Coherence Tomography Angiography of Asymptomatic Neovascularization in Intermediate Age-Related Macular Degeneration, Ophthalmology, vol.123, issue.6, pp.1309-1328, 2016. ,
DOI : 10.1016/j.ophtha.2016.01.044
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY VERSUS TRADITIONAL MULTIMODAL IMAGING IN ASSESSING THE ACTIVITY OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION, Retina, vol.35, issue.11, pp.2219-2247, 2015. ,
DOI : 10.1097/IAE.0000000000000766
CHARACTERIZING THE EFFECT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ON TREATMENT-NAIVE CHOROIDAL NEOVASCULARIZATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY, Retina, vol.35, issue.11, pp.2252-2261, 2015. ,
DOI : 10.1097/IAE.0000000000000836
Sequential Morphological Changes in the CNV Net after Intravitreal Anti-VEGF Evaluated with OCT Angiography, Ophthalmic Research, vol.55, issue.3, pp.145-51, 2016. ,
DOI : 10.1159/000442671
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF TIME COURSE OF CHOROIDAL NEOVASCULARIZATION IN RESPONSE TO ANTI-ANGIOGENIC TREATMENT, Retina, vol.35, issue.11, pp.2260-2264, 2015. ,
DOI : 10.1097/IAE.0000000000000846
Optical Coherence Tomography Angiography Study of Choroidal Neovascularization Early Response after Treatment, Dev Ophthalmol, vol.56, pp.77-85, 2016. ,
DOI : 10.1159/000442782
An international classification and grading system for age-related maculopathy and age-related macular degeneration, Survey of Ophthalmology, vol.39, issue.5, pp.367-74, 1995. ,
DOI : 10.1016/S0039-6257(05)80092-X
OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy, Eye, vol.125, issue.7, pp.932-937, 2015. ,
DOI : 10.1016/j.canlet.2013.05.015
URL : http://www.nature.com/eye/journal/v29/n7/pdf/eye201580a.pdf
Optical Coherence Tomography Angiography Signs of Vascular Abnormalization With Antiangiogenic Therapy for Choroidal Neovascularization, American Journal of Ophthalmology, vol.160, issue.1, pp.6-16, 2015. ,
DOI : 10.1016/j.ajo.2015.04.012
The Role of Angiogenic Growth Factors in Arteriogenesis, Journal of Vascular Research, vol.46, issue.4, pp.365-74, 2009. ,
DOI : 10.1159/000189797
Immunohistochemical study of the growth factors, aFGF, bFGF, PDGF-AB, VEGF-A and its receptor (Flk-1) during arteriogenesis, Molecular and Cellular Biochemistry, vol.274, issue.23, pp.223-232, 2010. ,
DOI : 10.1152/ajpheart.00478.2002
Basic and Therapeutic Aspects of Angiogenesis, Cell, vol.146, issue.6, pp.873-87, 2011. ,
DOI : 10.1016/j.cell.2011.08.039
Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival, The FASEB Journal, vol.15, issue.7, pp.1239-1280, 2001. ,
DOI : 10.1096/fj.00-0693fje
Platelet-Derived Growth Factor Production by B16 Melanoma Cells Leads to Increased Pericyte Abundance in Tumors and an Associated Increase in Tumor Growth Rate, Cancer Research, vol.64, issue.8, pp.2725-2758, 2004. ,
DOI : 10.1158/0008-5472.CAN-03-1489
Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy, Nature Medicine, vol.7, issue.9, pp.987-996, 2001. ,
DOI : 10.1038/nm0901-987
Ultrahigh-Speed Swept-Source OCT Angiography in Exudative AMD, Ophthalmic Surgery, Lasers and Imaging Retina, vol.45, issue.6, pp.496-505, 2014. ,
DOI : 10.3928/23258160-20141118-03
Quantitative Optical Coherence Tomography Angiography of Choroidal Neovascularization in Age-Related Macular Degeneration, Ophthalmology, vol.121, issue.7, pp.1435-1479, 2014. ,
DOI : 10.1016/j.ophtha.2014.01.034